FABP4 and obesity disorder: Recombinant FABP4 promotes inflammatory cytokine expression in 3T3-L1 adipocytes and in the AT of C57BL/6J mice via the p38/NF-κB pathway (94), further supporting its pro-inflammatory role in obesity-associated AT inflammation.